Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipodystrophies.

A Garg1

  • 1Department of Internal Medicine and the Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas 75235-9052, USA.

The American Journal of Medicine
|December 29, 2000
PubMed
Summary
This summary is machine-generated.

Lipodystrophies are rare genetic or acquired disorders causing fat loss and severe metabolic issues like diabetes. Management involves diet, drugs, and surgery to control complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spinal epidural arteriovenous malformations: clinical, imaging, and angioarchitectural characteristics with endovascular treatment outcomes-a single-centre experience.

Clinical radiology·2026
Same author

Endovascular management of life-threatening epistaxis from cavernous internal carotid artery lesions: an institutional experience.

Clinical radiology·2025
Same author

Abstracts of the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis and other Antiviral Drugs 2025, 3-4 September 2025, Amsterdam, the Netherlands.

British journal of clinical pharmacology·2025
Same author

Clinical insights and real-time PCR analysis of the first adeno-enterovirus conjunctivitis outbreak in India: A comprehensive cross-sectional study.

Journal of postgraduate medicine·2024
Same author

New-onset anxiety in paediatric patients with hidradenitis suppurativa.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Interpretation of comorbidity risk in hidradenitis suppurativa: comparing odds ratio and 'number needed to be exposed'.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric Panniculitis.

The American journal of medicine·2026
Same journal

Hypercalcemia and hyperferritinemia in a patient with Graves' disease disease.

The American journal of medicine·2026
See all related articles

Area of Science:

  • Endocrinology
  • Genetics
  • Metabolic Disorders

Background:

  • Lipodystrophies involve selective adipose tissue loss, leading to metabolic complications.
  • These rare disorders are classified as familial or acquired, with distinct clinical presentations.
  • Subtypes include congenital generalized lipodystrophy and familial partial lipodystrophy, Dunnigan type.

Purpose of the Study:

  • To review the classification and characteristics of lipodystrophies.
  • To highlight the genetic basis and metabolic consequences of these disorders.
  • To discuss current management strategies for lipodystrophy patients.

Main Methods:

  • Literature review of lipodystrophy classification and genetics.
  • Analysis of metabolic complications associated with fat loss.

Related Experiment Videos

  • Summary of clinical features and management approaches.

    • Main Results:

    • Familial lipodystrophies have subtypes with specific genetic localizations.
    • Acquired lipodystrophies often present with autoimmune links and affect women more.
    • HIV-associated lipodystrophy and localized forms have distinct causes and presentations.

    Conclusions:

    • Lipodystrophies present diverse clinical and genetic profiles.
    • Effective management requires addressing metabolic derangements and cosmetic concerns.
    • Further research is needed to identify causative genes and refine treatments.